Fluoxetine for depression relapse prevention [2] (multiple letters)

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 44, Issue 10, 2005, Pages 966-967

  Calarge, Chadi ^a   Kuperman, Samuel ^a   Emslie, Graham J ^b   Nilsson, Mary ^c   Jacobson, Jennie ^c   Heiligenstein, John ^c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO;

BODY HEIGHT; BODY WEIGHT; DEPRESSION; GROWTH CURVE; HUMAN; LETTER; PRIORITY JOURNAL; RELAPSE;

EID: 25444498062     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000172535.24534.44     Document Type: Letter

References (4)

1. GJ Emslie JH Heiligenstein SL Hoog Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study J Am Acad Child Adolesc Psychiatry 43 2004 1397 1405
2. National Center for Health Statistics CDC Growth Charts: United States Vital and Health Statistics 2000 National Center for Health Statistics, Centers for Disease Control and Prevention Hyattsville, MD
3. M Nilsson MJ Joliat CM Miner EB Brown JH Heiligenstein Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents J Child Adolesc Psychopharmacol 14 2004 412 417
4. N Weintrob D Cohen Y Klipper-Aurbach Z Zadik Z Dickerman Decreased growth during therapy with selective serotonin reuptake inhibitors Arch Pediatr Adolesc Med 156 2002 696 701